Significant bleeding due to traumatic injury is the number one cause of preventable deaths in the U.S., with the majority of deaths occurring within six hours.
Sparsentan Bests Irbesartan for Preserving Kidney Function in IgA Nephropathy
PHILADELPHIA — Sparsentan (Filspari) outperformed irbesartan in patients with IgA nephropathy over the 2-year phase III PROTECT trial. Over a 110-week treatment period, those on